RESUMEN
The role of vitamin D beyond its classical function in calcium homeostasis has been of significant interest in recent years. There has been expanding research on the pleiotropic role of vitamin D in pregnancy and the implications of its deficiency on maternal-fetal outcomes. Several studies have associated low maternal vitamin D status to adverse outcomes in pregnancy, including preeclampsia, gestational diabetes, preterm births, low birth weight, and others. Several randomized controlled clinical trials of Vitamin D supplementation during pregnancy have also been conducted. Though some of the studies found improvement in pregnancy outcomes with vitamin D supplementation, others have not shown any association. In this article, we have critically reviewed the observational and interventional studies, published primarily within the past two years (January 2014 to February 2016) on the influence of vitamin D deficiency on pregnancy and the impact of its supplementation. The potential underlying mechanisms of vitamin D in regulating each of the outcomes have also been discussed.
Asunto(s)
Suplementos Dietéticos , Complicaciones del Embarazo/etiología , Resultado del Embarazo , Deficiencia de Vitamina D/complicaciones , Vitamina D/uso terapéutico , Femenino , Humanos , Recién Nacido , Estudios Observacionales como Asunto , Embarazo , Complicaciones del Embarazo/prevención & control , Ensayos Clínicos Controlados Aleatorios como Asunto , Deficiencia de Vitamina D/tratamiento farmacológico , Deficiencia de Vitamina D/prevención & controlRESUMEN
Celiac Disease is an autoimmune enteropathy with increasing incidence worldwide in both adults and children. It occurs as an inflammatory condition with destruction of the normal architecture of villi on consumption of gluten and related protein products found in wheat, barley and rye. However, the exact pathogenesis is not yet fully understood. A gluten-free diet remains the main modality of therapy to date. While some patients continue to have symptoms even on a gluten-free diet, adherence to this diet is also difficult, especially for the children. Hence, there is continued interest in novel methods of therapy and the current research focus is on the promising novel non-dietary modalities of treatment. Here, we critically reviewed the existing literature regarding the pathogenesis of celiac disease in children including the role of in-utero exposure leading to neonatal and infant sensitization and its application for the development of new therapeutic approaches for these patients.
Asunto(s)
Enfermedad Celíaca/inmunología , Vellosidades Coriónicas/inmunología , Dietoterapia , Glútenes/inmunología , Mucosa Intestinal/inmunología , Adulto , Algoritmos , Autoinmunidad , Enfermedad Celíaca/diagnóstico , Enfermedad Celíaca/terapia , Niño , Predisposición Genética a la Enfermedad , Humanos , Lactante , Recién NacidoRESUMEN
Intrahepatic cholestasis of pregnancy poses a great risk to both maternal and fetal health. Despite extensive research, much of the pathogenesis of this disorder is unknown. The increase in bile acids observed in patients with intrahepatic cholestasis of pregnancy has been noted to cause a change in the immune system from the normally mediated TH2 response to one that is more oriented towards TH1. In this literature review, we have critically reviewed the current literature regarding the changes in the immune system and the potential effects of immunological changes in the management of the patient. The current treatment, ursodeoxycholic acid, is also discussed along with potential combination therapies and future directions for research.
Asunto(s)
Colestasis/inmunología , Complicaciones del Embarazo/inmunología , Células Th2/inmunología , Animales , Colestasis/tratamiento farmacológico , Femenino , Humanos , Inmunidad , Hígado/inmunología , Hígado/patología , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Balance Th1 - Th2 , Ácido Ursodesoxicólico/uso terapéuticoRESUMEN
Worldwide, preeclampsia is a significant health risk to both pregnant women and their unborn children. Despite scientific advances, the exact pathogenesis of preeclampsia is not yet fully understood. Meanwhile, the incidence of preeclampsia is expected to increase. A series of potential etiologies for preeclampsia has been identified, including endothelial dysfunction, immunological dysregulation and trophoblastic invasion. In this literature review, we have critically reviewed existing literature regarding the research findings that link the role of vitamin D to the pathogenesis and immunoregulation of preeclampsia. The relationship of vitamin D with the suspected etiologies of preeclampsia underscores its clinical potential in the diagnosis and treatment of preeclampsia.
Asunto(s)
Preeclampsia/diagnóstico , Preeclampsia/inmunología , Deficiencia de Vitamina D/inmunología , Vitamina D/inmunología , Antiinflamatorios no Esteroideos/uso terapéutico , Aspirina/uso terapéutico , Femenino , Humanos , Guías de Práctica Clínica como Asunto , Preeclampsia/tratamiento farmacológico , Embarazo , Linfocitos T/efectos de los fármacos , Linfocitos T/inmunología , Vitamina D/farmacología , Vitaminas/inmunología , Vitaminas/farmacologíaRESUMEN
OBJECTIVE: The purpose of this study was to test whether vasculopathy in type 1 diabetes mellitus (DM) is associated with fetal growth abnormalities. STUDY DESIGN: Women with type 1 DM (n = 340) were enrolled in a prospective study of diabetes in pregnancy and classified according to vascular status: NV (no vasculopathy, n = 181), HBR (hypertension or background retinopathy, n = 79), PR (proliferative retinopathy only, n = 16), NEP (nephropathy only, n = 40), and PRN (proliferative retinopathy and nephropathy, n = 24). Association of vascular status with low birthweight (LBW) and small for gestational age (SGA) infants was analyzed. RESULTS: The odds ratios for delivery of a LBW infant compared to women without vasculopathy after controlling for maternal age, gestational age and race were: HBR 1.0, PR 2.2, NEP 3.7, and PRN 5.5. The odds ratios for delivery of a SGA infant were: HBR 0.7, PR 10.4, NEP 1.9, and PRN 9.9. CONCLUSION: Diabetic vasculopathy is associated with increased odds for delivery of low-birthweight or SGA infants.
Asunto(s)
Diabetes Mellitus Tipo 1/epidemiología , Angiopatías Diabéticas/epidemiología , Retardo del Crecimiento Fetal/epidemiología , Recién Nacido de Bajo Peso , Embarazo en Diabéticas/epidemiología , Adulto , Peso al Nacer , Cesárea/estadística & datos numéricos , Comorbilidad , Femenino , Edad Gestacional , Humanos , Recién Nacido , Edad Materna , Oportunidad Relativa , Embarazo , Resultado del Embarazo , Nacimiento Prematuro/epidemiologíaRESUMEN
OBJECTIVE: The purpose of this study was to determine recurrence risk and pregnancy outcome in 23 women with a history of stroke. STUDY DESIGN: We conducted a descriptive study of 23 women (35 pregnancies) with a history of stroke. Charts were reviewed from 1990 through 2002. The data were analyzed for the antenatal treatment strategies, recurrence risk for stroke, and pregnancy outcome. RESULTS: There were 23 study patients with 35 subsequent pregnancies. Associated risk factors of the stroke were thrombophilia (5 women), sickle cell disease (3 women), maternal cardiac malformations (3 women), hypertension (3 women), oral contraceptive use (2 women), cerebral arteriovenous malformations (2 women), head trauma (1 woman), meningitis (1 woman), endocarditis (1 woman), and idiopathic reason (2 women). Four women with 9 subsequent pregnancies had a stroke that was associated with a previous pregnancy or postpartum incident. Two of these 9 pregnancies received anticoagulation (heparin, 1 pregnancy; heparin plus aspirin, 1 pregnancy). Nineteen women with 26 subsequent pregnancies had a stroke before pregnancy. Nine of these 26 pregnancies received anticoagulation (heparin, 5 pregnancies; aspirin, 3 pregnancies; heparin plus aspirin, 1 pregnancy). The remaining pregnancies did not receive prophylactic anticoagulation. Overall, there were 21 term deliveries, 8 preterm deliveries, 5 miscarriages, and 1 fetal death. Three of 34 pregnancies (9%) were small for gestational age infants. There were no recurrent thrombotic episodes during pregnancy or after delivery. Maternal complications included admission to the intensive care unit for uncontrolled hypertension in 1 patient. CONCLUSION: Women with a history of stroke have a low risk of recurrent stroke (0%). This information is useful for the prepregnancy counseling of such individuals. The need for prophylactic anticoagulation in patients with a previous stroke cannot be answered by this study.